Synergism between methamphetamine and the neuropeptide substance P on the production of nitric oxide in the striatum of mice

Brain Research

Volumn 1369, Issue , 2011, Pages 131-139

  Wang, Jing ^a   Angulo, Jesus A ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Methamphetamine; Neurokinin 1 receptor; Nitric oxide; SOM NPY NOS interneuron; Striatum; Substance P

Indexed keywords

17ALPHA ETHYNYL 17BETA HYDROXY 5ALPHA ANDROSTANO[3,2 B]PYRIMIDO[1,2 A]BENZIMIDAZOLE; 3 NITROTYROSINE; 5 AMINOVALERYLSUBSTANCE P [7-11][9 PROLINE 10 (N METHYLLEUCINE)]; 7 NITROINDAZOLE; CALMIDAZOLIUM; CITRULLINE; METHAMPHETAMINE; NEUROKININ 1 RECEPTOR; NEUROPEPTIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SUBSTANCE P;

ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; DRUG POTENTIATION; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CORPUS STRIATUM; DOPAMINE AGENTS; IMMUNOHISTOCHEMISTRY; MALE; METHAMPHETAMINE; MICE; MICE, INBRED ICR; MICROINJECTIONS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; RECEPTORS, NEUROKININ-1; SUBSTANCE P;

MUS;

EID: 78651078112     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.11.017     Document Type: Article

References (57)

1. H.M. Abu-Soud, and D.J. Stuehr Nitric oxide synthases reveal a role for calmodulin in controlling electron transfer Proc. Natl Acad. Sci. USA 90 1993 10769 10772
2. T. Andoh, T. Nagasawa, M. Satoh, and Y. Kuraishi Substance P induction of itch-associated response mediated by cutaneous NK1 tachykinin receptors in mice J. Pharmacol. Exp. Ther. 286 1998 1140 1145
3. A.J. Baucum II, K.S. Rau, E.L. Riddle, G.R. Hanson, and A.E. Fleckenstein Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanism J. Neurosci. 24 2004 3436 3443
4. K.M.K. Boje Nitric oxide neurotoxicity in neurodegenerative diseases Front. Biosci. 9 2004 763 776
5. D.S. Bredt, D.L. Ferris, and S.H. Snyder Nitric oxide synthase regulatory sites. Phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites J. Biol. Chem. 267 1992 10976 10981
6. J.M. Brown, and B.K. Yamamoto Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress Pharmacol. Ther. 99 2003 45 53
7. C. Cerruti, P. Sheng, B. Ladenheim, C.J. Epstein, and J.L. Cadet Involvement of oxidative and l-arginine-NO pathways in the neurotoxicity of drugs of abuse in vitro Clin. Exp. Pharmacol. Physiol. 22 1995 381 382
8. P. Chan, D.A. Di Monte, J.J. Luo, L.E. DeLanney, I. Irwin, and J.W. Langston Rapid ATP loss caused by methamphetamine in the mouse striatum: relationship between energy impairment and dopaminergic neurotoxicity J. Neurochem. 62 1994 2484 2487
9. X. Deng, Y. Wang, J. Chou, and J.L. Cadet Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method Brain Res. Mol. Brain Res. 93 2001 64 69
10. X. Deng, B. Ladenheim, S. Jayanthi, and J.L. Cadet Methamphetamine administration causes death of dopaminergic neurons in the mouse olfactory bulb Biol. Psychiatry 61 2007 1235 1243
11. A.J. Eisch, and J.F. Marshall Methamphetamine neurotoxicity: dissociation of striatal dopamine terminal damage from parietal cortical cell body injury Synapse 30 1998 433 445
12. P.J. Elliott, G.S. Mason, M. Stephen-Smith, and R.M. Hagan Behavioral and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists Neuropeptides 19 1991 119 126
13. P.J. Elliott, G.S. Mason, E.A. Graham, M.P. Turpin, and R.M. Hagan Modulation of the rat mesolimbic dopamine pathway by neurokinins Behav. Brain Res. 51 1992 77 82
14. J.F. Fischer, and A.K. Cho Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model J. Pharmacol. Exp. Ther. 208 1979 203 209
15. A.E. Fleckenstein, and G.R. Hanson Impact of psychostimulants on vesicular monoamine transporter function Eur. J. Pharmacol. 479 2003 283 289
16. A.E. Fleckenstein, R.R. Metzger, M.L. Beyeler, J.W. Gibb, and G.R. Hanson Oxygen radicals diminish dopamine transporter function in rat striatum Eur. J. Pharmacol. 334 1997 111 114
17. B. Fornstedt, and A. Carlsson A marked rise in 5-S-cysteinyl-dopamine levels in guinea-pig striatum following reserpine treatment J. Neural Transm. 76 1989 155 161
18. K.B.J. Franklin, and G. Paxinos The Mouse Brain in Stereotaxic Coordinates 1997 The Aademic Press New York
19. E. Galarraga, S. Hernandez-Lopez, D. Tapia, A. Reyes, and J. Bargas Action of substance P (neurokinin-1) receptor activation on rat neostriatal projection neurons Synapse 33 1999 26 35
20. C.R. Gerfen The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia Annu. Rev. Neurosci. 15 1992 285 320
21. R.M. Hagan, S.J. Ireland, C.C. Jordan, I.J. Beresford, M.J. Deal, and P. Ward Receptor-selective, peptidase-resistant agonists at neurokinin NK-1 and NK-2 receptors: new tools for investigating neurokinin function Neuropeptides 19 1991 127 135
22. J.M. Hall, and I.K. Morton Novel selective agonists and antagonists confirm neurokinin NK1 receptors in guinea-pig vas deferens Br. J. Pharmacol. 102 1991 511 517
23. J.M. Hall, D. Mitchell, and I.K. Morton Neurokinin receptors in the rabbit iris sphincter characterized by novel agonist ligands Eur. J. Pharmacol. 199 1991 9 14
24. T.G. Hastings, D.A. Lewis, and M.J. Zigmond Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections Proc. Natl Acad. Sci. USA 93 1996 1956 1961
25. Y. Hayashi, M. Nishio, Y. Naito, H. Yokokura, Y. Nimura, H. Hidaka, and Y. Watanabe Regulation of neuronal nitric oxide synthase by calmodulin kinases Biol. Chem. 274 1999 20597 20602
26. K. Hirata, R. Kuroda, T. Sakoda, M. Katayama, N. Inoue, M. Suematsu, S. Kawashima, and M. Yokoyama Inhibition of endothelial nitric oxide synthase activity by protein kinase C Hypertension 25 1995 180 185
27. A.J. Hotchkiss, M.E. Morgan, and J.W. Gibb The long-term effects of multiple doses of methamphetamine on neostriatal tryptophan hydroxylase, tyrosine hydroxylase, choline acetyltransferase and glutamate decarboxylase activities Life Sci. 25 1979 1373 1378
28. S.Z. Imam, G.D. Newport, Y. Itzhak, J.L. Cadet, F. Islam, W. Slikker Jr., and S.F. Ali Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase J. Neurochem. 76 2001 745 749
29. Y. Itzhak, and S.F. Ali The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo J. Neurochem. 67 1996 1770 1773
30. Y. Itzhak, J.J. Martin, and S.F. Ali nNOS inhibitors attenuate methamphetamine-induced dopaminergic neurotoxicity but not hyperthermia in mice NeuroReport 11 2000 2943 2946
31. S.R. Jones, R.R. Gainetdinov, R.M. Wightman, and M.G. Caron Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter J. Neurosci. 18 1998 1979 1986
32. Y. Kawaguchi, C.J. Wilson, S.J. Augood, and P.C. Emson Striatal interneurons-chemical, physiological and morphological characterization Trends Neurosci. 18 1995 527 535
33. S.Z. Khan, J.L. Dyer, and F. Michelangeli Inhibition of the type 1 inositol 1,4,5-triphosphate-sensitive Ca2+ channel by calmodulin antagonists Cell. Signal. 13 2001 57 63
34. M.J. LaVoie, J.P. Card, and T.G. Hastings Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity Exp. Neurol. 187 2004 47 57
35. F.C. Martin, P.A. Anton, J.A. Gornbein, F. Shanahan, and J.E. Merrill Production of interleukin-1 by microglia in response to substance P: role for a non-classical NK-1 receptor J. Immunol. 42 1993 53 60
36. A. Matsuoka, D.J. Stuehr, J.S. Olson, P. Clark, and M. Ikeda-Saito l-arginine and calmodulin regulation of the heme iron reactivity in neuronal nitric oxide synthase J. Biol. Chem. 269 1994 20335 20339
37. J.F. Nash, and B.K. Yamamoto Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine Brain Res. 581 1992 237 243
38. M.C. O'Shaughnessy, E.-K. Vetsika, J.J. Inglis, J. Carleson, R. Haigh, B.L. Kidd, and P.G. Winyard The effect of substance P on nitric oxide release in a rheumatoid arthritis model Inflamm. Res. 55 2006 263-40
39. V. Ralevic, Z. Khalil, R.D. Helme, and G.J. Dusting Role of nitric oxide in the actions of substance P and other mediators of inflammation in rat skin microvasculature Eur. J. Pharmacol. 284 1995 231 239
40. A. Rasley, K.L. Bost, J.K. Olson, S.D. Miller, and I. Marriott Expression of functional NK-1 receptors in murine microglia Glia 37 2002 258 267
41. G.A. Ricaurte, R.W. Guillery, L.S. Seiden, C.R. Schuster, and R.Y. Moore Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain Brain Res. 235 1982 93 103
42. C. Sakurada, C. Watanabe, M. Inoue, K. Tan-No, R. Ando, K. Kisara, and T. Sakurada Spinal actions of GR73632, a novel tachykinin NK1 receptor agonist Peptides 20 1999 301 304
43. D.E. Spratt, V. Taiakina, M. Palmer, and J.G. Guillemette Differential binding of calmodulin domains to constitutive and inducible nitric oxide synthase enzymes Biochem. 46 2007 8288 8300
44. D. Sulzer, T.-K. Chen, Y.Y. Lau, H. Kristensen, S. Rayport, and A. Ewing Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport J. Neurosci. 15 1995 4102 4108
45. H.B. Tang, Y.S. Li, K. Arihiro, and Y. Nakata Activation of the neurokinin-1 receptor by substance P triggers the release of substance P from cultured adult rat dorsal root ganglion neurons Mol. Pain 3 2007 42 51
46. T. Taraska, and K.T. Finnegan Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-methylenedioxymethamphetamine J. Pharm. Exp. Ther. 280 1997 941 947
47. D.M. Thomas, P.D. Walker, J.A. Benjamins, T.J. Geddes, and D.M. Kuhn Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation J. Pharm. Exp. Ther. 311 2004 1 7
48. P.M. Thompson, K.M. Hayashi, S.L. Simon, J.A. Geaga, M.S. Hong, Y. Sui, J.Y. Lee, A.W. Toga, W. Ling, and E.D. London Structural abnormalities in the brains of human subjects who use methamphetamine J. Neurosci. 24 2004 6028 6036
49. H.-P. Too, D.R. Marriott, and G.P. Wilkin Preprotachykinin-A and substance P receptor (NK1) gene expression in rat astrocytes in vitro Neurosci. Lett. 182 1994 185 187
50. Y. Torrens, J.C. Beaujouan, M. Saffroy, M.C. Daguet de Montety, L. Bergstrom, and J. Glowinski Substance P receptors in primary cultures of cortical astrocytes from mouse Proc. Natl Acad. Sci. USA 83 1986 9216 9220
51. G.C. Wagner, G.A. Ricaurte, L.S. Seiden, C.R. Schuster, R.J. Miller, and J. Westley Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine Brain Res. 181 1980 151 160
52. Wang, J., Angulo, J.A., 2010. Methamphetamine induces striatal neurokinin-1 receptor endocytosis primarily in somatostatin/NPY/NOS interneurons and the role of dopamine receptors in mice. Synapse (in press).
53. M.D. Womack, M.R. Hanley, and T.M. Jessell Functional substance P receptors on a rat pancreatic acinar cell line J. Neurosci. 5 1985 3370 3378
54. M.D. Womack, A.B. MacDermott, and T.M. Jessell Sensory transmitters regulate intracellular calcium in dorsal horn neurons Nature 334 1988 351 353
55. J. Yu, J. Wang, J.L. Cadet, and J.A. Angulo Histological evidence supporting a role for the striatal neurokinin-1 receptor in methamphetamine- induced neurotoxicity in the mouse brain Brain Res. 1007 2004 124 131
56. J. Zhu, W. Xu, and J.A. Angulo Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice Neurosci. 140 2006 607 622
57. J. Zhu, W. Xu, J. Wang, S.F. Ali, and J.A. Angulo The neurokinin-1 receptor modulates the methamphetamine-induced striatal apoptosis and nitric oxide formation in mice J. Neurochem. 111 2009 656 668